- Home
- TEVA vs FDS Comparison
TEVA vs FDS Comparison
Compare TEVA & FDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- FDS
- Stock Information
- Founded
- TEVA 1901
- FDS 1978
- Country
- TEVA Israel
- FDS United States
- Employees
- TEVA N/A
- FDS N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- FDS Computer Software: Programming Data Processing
- Sector
- TEVA Health Care
- FDS Technology
- Exchange
- TEVA Nasdaq
- FDS Nasdaq
- Market Cap
- TEVA 20.1B
- FDS 17.6B
- IPO Year
- TEVA N/A
- FDS 1996
- Fundamental
- Price
- TEVA $17.15
- FDS $447.94
- Analyst Decision
- TEVA Strong Buy
- FDS Sell
- Analyst Count
- TEVA 8
- FDS 9
- Target Price
- TEVA $24.50
- FDS $444.25
- AVG Volume (30 Days)
- TEVA 10.5M
- FDS 378.4K
- Earning Date
- TEVA 07-30-2025
- FDS 06-23-2025
- Dividend Yield
- TEVA N/A
- FDS 0.98%
- EPS Growth
- TEVA N/A
- FDS 4.49
- EPS
- TEVA N/A
- FDS 13.85
- Revenue
- TEVA $16,616,000,000.00
- FDS $2,287,034,000.00
- Revenue This Year
- TEVA $5.69
- FDS $5.94
- Revenue Next Year
- TEVA N/A
- FDS $5.74
- P/E Ratio
- TEVA N/A
- FDS $32.33
- Revenue Growth
- TEVA 3.82
- FDS 5.07
- 52 Week Low
- TEVA $12.47
- FDS $391.69
- 52 Week High
- TEVA $22.80
- FDS $499.87
- Technical
- Relative Strength Index (RSI)
- TEVA 50.50
- FDS 59.92
- Support Level
- TEVA $16.55
- FDS $434.96
- Resistance Level
- TEVA $16.95
- FDS $451.08
- Average True Range (ATR)
- TEVA 0.43
- FDS 8.76
- MACD
- TEVA -0.06
- FDS 2.93
- Stochastic Oscillator
- TEVA 45.04
- FDS 95.68
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About FDS FactSet Research Systems Inc.
FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for roughly 82% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.